{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:28:07Z","timestamp":1795030087870,"version":"4.10.2"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100005941","name":"Dietmar Hopp Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005941","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck Serono"},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["Competence Network Multiple Sclerosis"],"award-info":[{"award-number":["Competence Network Multiple Sclerosis"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["Competence Network Multiple Sclerosis"],"award-info":[{"award-number":["Competence Network Multiple Sclerosis"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG EXC 257"],"award-info":[{"award-number":["DFG EXC 257"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003413","name":"Bundesministerium f\u00fcr Wissenschaft, Forschung und Wirtschaft","doi-asserted-by":"publisher","award":["Big Wig MS"],"award-info":[{"award-number":["Big Wig MS"]}],"id":[{"id":"10.13039\/501100003413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["FWF project I916"],"award-info":[{"award-number":["FWF project I916"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Research Area","award":["E-RARE-2"],"award-info":[{"award-number":["E-RARE-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12974-016-0719-z","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T03:44:48Z","timestamp":1477971888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":217,"title":["MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome"],"prefix":"10.1186","volume":"13","author":[{"name":"in cooperation with the Neuromyelitis Optica Study Group (NEMOS)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Jarius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Kleiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Ruprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Pitarokoili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Borisow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"H\u00fcmmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Trebst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Pache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Winkelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena-Alexandra","family":"Beume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Ringelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Stich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Korporal-Kuhnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Buttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bellmann-Strobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander U.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Schanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Wildemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"key":"719_CR1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","volume":"9","author":"M Reindl","year":"2013","unstructured":"Reindl M, Di Pauli F, Rostasy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol. 2013;9:455\u201361.","journal-title":"Nat Rev Neurol"},{"key":"719_CR2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","volume":"8","author":"S Mader","year":"2011","unstructured":"Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation. 2011;8:184.","journal-title":"J Neuroinflammation"},{"key":"719_CR3","doi-asserted-by":"publisher","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume L, H\u00fcmmert MW, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflammation. 2016. doi: 10.1186\/s12974-016-0717-1 .","DOI":"10.1186\/s12974-016-0717-1"},{"key":"719_CR4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","volume":"79","author":"J Kitley","year":"2012","unstructured":"Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, Palace J, Vincent A. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology. 2012;79:1273\u20137.","journal-title":"Neurology"},{"key":"719_CR5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","volume":"71","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, Kuker W, Chandratre S, Vincent A, Palace J. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014;71:276\u201383.","journal-title":"JAMA Neurol"},{"key":"719_CR6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA, Waters PJ, de Haidar Jorge FM, Takahashi T, Nakashima I, Apostolos-Pereira SL, Talim N, Simm RF, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. 2014;82:474\u201381.","journal-title":"Neurology"},{"key":"719_CR7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-015-0256-1","volume":"12","author":"AK Probstel","year":"2015","unstructured":"Probstel AK, Rudolf G, Dornmair K, Collongues N, Chanson JB, Sanderson NS, Lindberg RL, Kappos L, de Seze J, Derfuss T. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflammation. 2015;12:46.","journal-title":"J Neuroinflammation"},{"key":"719_CR8","doi-asserted-by":"crossref","first-page":"e007766","DOI":"10.1136\/bmjopen-2015-007766","volume":"5","author":"H Nakajima","year":"2015","unstructured":"Nakajima H, Motomura M, Tanaka K, Fujikawa A, Nakata R, Maeda Y, Shima T, Mukaino A, Yoshimura S, Miyazaki T, et al. Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis. BMJ Open. 2015;5:e007766.","journal-title":"BMJ Open"},{"key":"719_CR9","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC, Reindl M, Lang B, Sato DK, Jurynczyk M, Tackley G, Rocha J, Takahashi T, et al. MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm. 2015;2:e89.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"719_CR10","doi-asserted-by":"crossref","unstructured":"van Pelt ED, Wong YY, Ketelslegers IA, Hamann D, Hintzen RQ. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. Eur J Neurol. 2016;23:580\u20137.","DOI":"10.1111\/ene.12898"},{"key":"719_CR11","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archneur.65.11.1527","volume":"65","author":"FB Konig","year":"2008","unstructured":"Konig FB, Wildemann B, Nessler S, Zhou D, Hemmer B, Metz I, Hartung HP, Kieseier BC, Bruck W. Persistence of immunopathological and radiological traits in multiple sclerosis. Arch Neurol. 2008;65:1527\u201332.","journal-title":"Arch Neurol"},{"key":"719_CR12","doi-asserted-by":"publisher","unstructured":"Jarius S, Metz I, K\u00f6nig F, Ruprecht K, Reindl M, Paul F, Br\u00fcck W, Wildemann B. Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in \u2018pattern II multiple sclerosis\u2019 and brain biopsy findings in a MOG-IgG-positive case. Mult Scler. doi: 10.1177\/1352458515622986 .","DOI":"10.1177\/1352458515622986"},{"key":"719_CR13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acn3.164","volume":"2","author":"M Spadaro","year":"2015","unstructured":"Spadaro M, Gerdes LA, Mayer MC, Ertl-Wagner B, Laurent S, Krumbholz M, Breithaupt C, Hogen T, Straube A, Giese A, et al. Histopathology and clinical course of MOG-antibody-associated encephalomyelitis. Ann Clin Transl Neurol. 2015;2:295\u2013301.","journal-title":"Ann Clin Transl Neurol"},{"key":"719_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2051-5960-2-35","volume":"2","author":"S Saadoun","year":"2014","unstructured":"Saadoun S, Waters P, Owens GP, Bennett JL, Vincent A, Papadopoulos MC. Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain. Acta Neuropathol Commun. 2014;2:35.","journal-title":"Acta Neuropathol Commun"},{"key":"719_CR15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"D Wingerchuk","year":"2015","unstructured":"Wingerchuk D, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, et al. International Consensus Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders. Neurology 2015;85:177\u201389.","journal-title":"Neurology"},{"key":"719_CR16","doi-asserted-by":"crossref","unstructured":"Sven Jarius, Brigitte Wildemann. The history of neuromyelitis optica. J Neuroinflammation. 2013;10:8.","DOI":"10.1186\/1742-2094-10-8"},{"key":"719_CR17","doi-asserted-by":"publisher","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume L, H\u00fcmmert MW, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016. doi: 10.1186\/s12974-016-0718-0","DOI":"10.1186\/s12974-016-0718-0"},{"key":"719_CR18","doi-asserted-by":"publisher","unstructured":"Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J Neuroinflammation. 2016. doi: 10.1186\/s12974-016-0720-6 .","DOI":"10.1186\/s12974-016-0720-6"},{"key":"719_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","volume":"261","author":"C Trebst","year":"2013","unstructured":"Trebst C, Jarius S, Berthele A, Paul F, Schippling S, Wildemann B, Borisow N, Kleiter I, Aktas O, Kumpfel T. Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol. 2013;261:1\u201316.","journal-title":"J Neurol"},{"key":"719_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation. 2012;9:14.","journal-title":"J Neuroinflammation"},{"key":"719_CR21","doi-asserted-by":"crossref","unstructured":"Ayzenberg I, Sch\u00f6llhammer J, Hoepner R, Hellwig K, Ringelstein M, Aktas O, K\u00fcmpfel T, Krumbholz M, Trebst C, Paul F, et al. Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study. J Neurol. 2016;263:575\u201382.","DOI":"10.1007\/s00415-015-7991-1"},{"key":"719_CR22","doi-asserted-by":"crossref","unstructured":"Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, et al. Neuromyelitis optica: Evaluation of 871 attacks and 1153 treatment courses. Ann Neurol. 2016;79:206\u201316.","DOI":"10.1002\/ana.24554"},{"key":"719_CR23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00115-010-3192-4","volume":"82","author":"C Trebst","year":"2011","unstructured":"Trebst C, Berthele A, Jarius S, Kumpfel T, Schippling S, Wildemann B, Wilke C. [Diagnosis and treatment of neuromyelitis optica. Consensus recommendations of the Neuromyelitis Optica Study Group]. Nervenarzt. 2011;82:768\u201377.","journal-title":"Nervenarzt"},{"key":"719_CR24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","volume":"291","author":"S Jarius","year":"2010","unstructured":"Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci. 2010;291:52\u20136.","journal-title":"J Neurol Sci"},{"key":"719_CR25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","volume":"23","author":"S Jarius","year":"2013","unstructured":"Jarius S, Wildemann B. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol. 2013;23:661\u201383.","journal-title":"Brain Pathol"},{"key":"719_CR26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1742-2094-11-129","volume":"11","author":"S Jarius","year":"2014","unstructured":"Jarius S, Paul F, Fechner K, Ruprecht K, Kleiter I, Franciotta D, Ringelstein M, Pache F, Aktas O, Wildemann B. Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate. J Neuroinflammation. 2014;11:129.","journal-title":"J Neuroinflammation"},{"key":"719_CR27","doi-asserted-by":"crossref","unstructured":"Kremer L, Mealy M, Jacob A, Nakashima I, Cabre P, Bigi S, Paul F, Jarius S, Aktas O, Elsone L, et al. Brainstem manifestations in neuromyelitis optica:a multicenter study of 258 patients. Mult Scler. 2014;20:843-7.","DOI":"10.1177\/1352458513507822"},{"key":"719_CR28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-13-33","volume":"13","author":"N Asgari","year":"2013","unstructured":"Asgari N, Skejoe HP, Lillevang ST, Steenstrup T, Stenager E, Kyvik KO. Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study. BMC Neurol. 2013;13:33.","journal-title":"BMC Neurol"},{"key":"719_CR29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","volume":"21","author":"L Pandit","year":"2015","unstructured":"Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI, Kleiter I, Chitnis T. Demographic and clinical features of neuromyelitis optica: A review. Mult Scler. 2015;21:845\u201353.","journal-title":"Mult Scler"},{"key":"719_CR30","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology. 1999;53:1107\u201314.","journal-title":"Neurology"},{"key":"719_CR31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ana.22121","volume":"68","author":"M Apiwattanakul","year":"2010","unstructured":"Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, McKeon A, Carpenter AF, Miller GM, Pittock SJ. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010;68:757\u201361.","journal-title":"Ann Neurol"},{"key":"719_CR32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1212\/WNL.0b013e318297ef07","volume":"81","author":"N Asgari","year":"2013","unstructured":"Asgari N, Skejoe HP, Lennon VA. Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient. Neurology. 2013;81:95\u20136.","journal-title":"Neurology"},{"key":"719_CR33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cgh.2012.11.021","volume":"11","author":"R Iorio","year":"2013","unstructured":"Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, Pittock SJ. Intractable nausea and vomiting from autoantibodies against a brain water channel. Clin Gastroenterol Hepatol. 2013;11:240\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"719_CR34","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e318214332c","volume":"76","author":"BF Popescu","year":"2011","unstructured":"Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Weinshenker BG, Lucchinetti CF. Neuromyelitis optica unique area postrema lesions: Nausea, vomiting, and pathogenic implications. Neurology. 2011;76:1229\u201337.","journal-title":"Neurology"},{"key":"719_CR35","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0140-6736(09)62066-3","volume":"375","author":"J Riphagen","year":"2010","unstructured":"Riphagen J, Modderman P, Verrips A. Hiccups, nausea, and vomiting: water channels under attack! Lancet. 2010;375:954.","journal-title":"Lancet"},{"key":"719_CR36","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica laboratory features, treatment responses, and long-term outcome. Neurology. 2006;66:1485\u20139.","journal-title":"Neurology"},{"key":"719_CR37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337\u201341.","journal-title":"Nature"},{"key":"719_CR38","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/1352458511404917","volume":"17","author":"W Kim","year":"2011","unstructured":"Kim W, Kim SH, Lee SH, Li XF, Kim HJ. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler. 2011;17:1107\u201312.","journal-title":"Mult Scler"},{"key":"719_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2010.12.001","volume":"302","author":"JE Kim","year":"2011","unstructured":"Kim JE, Kim SM, Ahn SW, Lim BC, Chae JH, Hong YH, Park KS, Sung JJ, Lee KW. Brain abnormalities in neuromyelitis optica. J Neurol Sci. 2011;302:43\u20138.","journal-title":"J Neurol Sci"},{"key":"719_CR40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ana.23721","volume":"73","author":"E Saji","year":"2013","unstructured":"Saji E, Arakawa M, Yanagawa K, Toyoshima Y, Yokoseki A, Okamoto K, Otsuki M, Akazawa K, Kakita A, Takahashi H, et al. Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol. 2013;73:65\u201376.","journal-title":"Ann Neurol"},{"key":"719_CR41","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1111\/j.1468-1331.2012.03667.x","volume":"19","author":"M Tahara","year":"2012","unstructured":"Tahara M, Ito R, Tanaka K, Tanaka M. Cortical and leptomeningeal involvement in three cases of neuromyelitis optica. Eur J Neurol. 2012;19:e47\u20138.","journal-title":"Eur J Neurol"},{"key":"719_CR42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jns.2011.09.025","volume":"313","author":"S Jarius","year":"2012","unstructured":"Jarius S, Wildemann B. \u2018Noteomielite\u2019 accompanied by acute amaurosis (1844). An early case of neuromyelitis optica. J Neurol Sci. 2012;313:182\u20134.","journal-title":"J Neurol Sci"},{"key":"719_CR43","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","volume":"84","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, Klawiter EC, Sato DK, de Seze J, Wuerfel J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015;84:1165\u201373.","journal-title":"Neurology"},{"key":"719_CR44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10072-008-0002-x","volume":"30","author":"D Lepur","year":"2009","unstructured":"Lepur D, Peterkovic V, Kalabric-Lepur N. Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis. Neurol Sci. 2009;30:51\u20134.","journal-title":"Neurol Sci"},{"key":"719_CR45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","volume":"306","author":"S Jarius","year":"2011","unstructured":"Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci. 2011;306:82\u201390.","journal-title":"J Neurol Sci"},{"key":"719_CR46","doi-asserted-by":"crossref","unstructured":"Jarius S, Wildemann B. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: A potential link. Med Hypotheses. 2013;81:1090\u20135.","DOI":"10.1016\/j.mehy.2013.10.011"},{"key":"719_CR47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1742-2094-7-52","volume":"7","author":"S Jarius","year":"2010","unstructured":"Jarius S, Franciotta D, Paul F, Ruprecht K, Bergamaschi R, Rommer PS, Reuss R, Probst C, Kristoferitsch W, Wandinger KP, Wildemann B. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation. 2010;7:52.","journal-title":"J Neuroinflammation"},{"key":"719_CR48","doi-asserted-by":"crossref","first-page":"e0149411","DOI":"10.1371\/journal.pone.0149411","volume":"11","author":"K Kothur","year":"2016","unstructured":"Kothur K, Wienholt L, Tantsis EM, Earl J, Bandodkar S, Prelog K, Tea F, Ramanathan S, Brilot F, Dale RC. B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine\/Chemokines Are Elevated in MOG Antibody Associated Demyelination. PLoS One. 2016;11:e0149411.","journal-title":"PLoS One"},{"key":"719_CR49","first-page":"1176","volume":"69","author":"MA Mealy","year":"2012","unstructured":"Mealy MA, Wingerchuk DM, Greenberg BM, Levy M. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol. 2012;69:1176\u201380.","journal-title":"Arch Neurol"},{"key":"719_CR50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jns.2008.08.015","volume":"276","author":"K Heerlein","year":"2009","unstructured":"Heerlein K, Jarius S, Jacobi C, Rohde S, Storch-Hagenlocher B, Wildemann B. Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection. J Neurol Sci. 2009;276:184\u20136.","journal-title":"J Neurol Sci"},{"key":"719_CR51","doi-asserted-by":"crossref","first-page":"P534","DOI":"10.1177\/1352458506071356","volume":"13","author":"S Jarius","year":"2007","unstructured":"Jarius S, Paul F, Martins da Silva A, Leite MI, Waters P, Littleton E, Franciotta D, Palace J, Zipp F, Vincent A. Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis. Mult Scler. 2007;13:P534.","journal-title":"Mult Scler"},{"key":"719_CR52","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","volume":"78","author":"MI Leite","year":"2012","unstructured":"Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D, Melamud L, Marta M, Graham A, Spillane J, et al. Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology. 2012;78:1601\u20137.","journal-title":"Neurology"},{"key":"719_CR53","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.0b013e3181a82621","volume":"72","author":"S Nishiyama","year":"2009","unstructured":"Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, Jin K, Aoki M, Fujihara K, Itoyama Y. A case of NMO seropositive for aquaporin-4 antibody more than 10\u00a0years before onset. Neurology. 2009;72:1960\u20131.","journal-title":"Neurology"},{"key":"719_CR54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/WCO.0b013e3280be58d8","volume":"20","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lucchinetti CF. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol. 2007;20:343\u201350.","journal-title":"Curr Opin Neurol"},{"key":"719_CR55","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1212\/WNL.0b013e3181aa53bb","volume":"72","author":"B Wildemann","year":"2009","unstructured":"Wildemann B, Jarius S, Hartmann M, Regula JU, Hametner C. Acute disseminated encephalomyelitis following vaccination against human papilloma virus. Neurology. 2009;72:2132\u20133.","journal-title":"Neurology"},{"key":"719_CR56","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1111\/j.1468-1331.2010.03204.x","volume":"18","author":"Y Furukawa","year":"2011","unstructured":"Furukawa Y, Komai K, Yamada M. Neuromyelitis optica after Japanese encephalitis vaccination. Eur J Neurol. 2011;18:e26\u20137.","journal-title":"Eur J Neurol"},{"key":"719_CR57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.0b013e31825fdead","volume":"79","author":"T Menge","year":"2012","unstructured":"Menge T, Cree B, Saleh A, Waterboer T, Berthele A, Kalluri SR, Hemmer B, Aktas O, Hartung HP, Methner A, Kieseier BC. Neuromyelitis optica following human papillomavirus vaccination. Neurology. 2012;79:285\u20137.","journal-title":"Neurology"},{"key":"719_CR58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25\u201336.","journal-title":"Ann Neurol"},{"key":"719_CR59","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.3800793","volume":"20","author":"JH Phi","year":"2007","unstructured":"Phi JH, Park SH, Paek SH, Kim SK, Lee YJ, Park CK, Cho BK, Lee DH, Wang KC. Expression of Sox2 in mature and immature teratomas of central nervous system. Mod Pathol. 2007;20:742\u20138.","journal-title":"Mod Pathol"},{"key":"719_CR60","doi-asserted-by":"crossref","unstructured":"Bartakova A, Ondic O, Presl J, Vlasak P, Bouda J. Oligodendroglioma originating in mature cystic teratoma. J Obstet Gynaecol. 2015;1\u20132.","DOI":"10.3109\/01443615.2015.1049990"},{"key":"719_CR61","first-page":"745462","volume":"2014","author":"B Unal","year":"2014","unstructured":"Unal B, Gulec F, Sedele M. Oligodendroglioma arising in mature cystic teratoma. Case Rep Oncol Med. 2014;2014:745462.","journal-title":"Case Rep Oncol Med"},{"key":"719_CR62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/PGP.0b013e318196c4c0","volume":"28","author":"I Opris","year":"2009","unstructured":"Opris I, Ducrotoy V, Bossut J, Lamy A, Sabourin JC. Oligodendroglioma arising in an ovarian mature cystic teratoma. Int J Gynecol Pathol. 2009;28:367\u201371.","journal-title":"Int J Gynecol Pathol"},{"key":"719_CR63","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1034\/j.1600-0412.2002.810918.x","volume":"81","author":"GF Zannoni","year":"2002","unstructured":"Zannoni GF, Fadda G, Scambia G, Capelli A, Carbone A. Oligodendroglioma arising within a mature cystic ovarian teratoma: case report and review of the literature. Acta Obstet Gynecol Scand. 2002;81:896\u20137.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"719_CR64","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jocn.2010.12.011","volume":"18","author":"I Nakashima","year":"2011","unstructured":"Nakashima I, Takahashi T, Cree BA, Kim HJ, Suzuki C, Genain CP, Vincent T, Fujihara K, Itoyama Y, Bar-Or A. Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels. J Clin Neurosci. 2011;18:997\u20138.","journal-title":"J Clin Neurosci"},{"key":"719_CR65","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archneurol.2010.188","volume":"67","author":"J Palace","year":"2010","unstructured":"Palace J, Leite MI, Nairne A, Vincent A. Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol. 2010;67:1016\u20137.","journal-title":"Arch Neurol"},{"key":"719_CR66","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00415-007-0730-5","volume":"255","author":"Y Shimizu","year":"2008","unstructured":"Shimizu Y, Yokoyama K, Misu T, Takahashi T, Fujihara K, Kikuchi S, Itoyama Y, Iwata M. Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol. 2008;255:305\u20137.","journal-title":"J Neurol"},{"key":"719_CR67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2006.10.008","volume":"252","author":"Y Warabi","year":"2007","unstructured":"Warabi Y, Matsumoto Y, Hayashi H. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci. 2007;252:57\u201361.","journal-title":"J Neurol Sci"},{"key":"719_CR68","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.expneurol.2013.02.005","volume":"247","author":"R Khorooshi","year":"2013","unstructured":"Khorooshi R, Wlodarczyk A, Asgari N, Owens T. Neuromyelitis optica-like pathology is dependent on type I interferon response. Exp Neurol. 2013;247:744\u20137.","journal-title":"Exp Neurol"},{"key":"719_CR69","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2014.01.019","volume":"339","author":"N Asgari","year":"2014","unstructured":"Asgari N, Kyvik KO, Steenstrup T, Stenager E, Lillevang ST. Antibodies against interferon-beta in neuromyelitis optica patients. J Neurol Sci. 2014;339:52\u20136.","journal-title":"J Neurol Sci"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0719-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T01:30:32Z","timestamp":1568511032000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-016-0719-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1186\/s12974-016-0719-z","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]},"article-number":"281"}}